Potential technique for reducing side effects of Alzheimer’s immunotherapy revealed

Written by Alice Weatherston

Although immunotherapy represents an exciting opportunity for the treatment of Alzheimer’s Disease, success in clinical trials has so far been hindered by the presence of notable inflammatory side effects as a result of the regimens. New research from the University of Southampton (UK) however has revealed a possible solution to the adverse effects of Alzheimer’s immunotherapy treatments, bringing new hope to the field of research. Thus far, antibodies developed to target amyloid-beta have illustrated success in clearing plaques and reversing cognitive decline in mouse models, however the translation into clinical trials has proven more problematic. Patients have reported considerable side...

To view this content, please register now for access

It's completely free